OMCL
Omnicell, Inc.

Omnicell, Inc.OMCL

Healthcare · Health Information Services
33.17USD
+2.28%
Sep 23, 2026
OMCL overview ready
Specialist provider of autonomous medication management and pharmacy automation
Omnicell is a specialist medication-management technology provider to hospitals and health systems, selling and servicing automated dispensing systems, central-pharmacy automation and robotics, IV-compounding workflow, connected software and analytics, and related technical, SaaS, and expert services.
Narrative not measured
Healthcare Delivery Labor Productivity and AutomationHospital Pharmacy and Medication-Workflow AutomationPure play
Price trend is broken
Longer-term context reads damaged structure, with a near-term setup of distribution pressure.
The tactical setup reads distribution pressure, but the weekly structure is broken.
Attractive valuation
Current market expectations look undemanding relative to the cash the business actually produces.
Solid fundamentals
Free cash flow yield is strong.
Primary risk
Dependence on hospital and health system capital spending.
Market Sep 22Filing Jun 30Price action Sep 22Research Jul 29

Conviction Level

NarrativeHeat—ThemeHeat6.1PriceAction3.4Valuation7.9CompanyPosition7.3
Price
Loading price history…

Price Action

Price trend is broken
Longer-term context reads damaged structure, with a near-term setup of distribution pressure.
The tactical setup reads distribution pressure, but the weekly structure is broken.
EntryWeak / unconfirmed recovery

The daily chart may be improving, but the weekly fast averages have not been reclaimed — the recovery is not yet confirmed on the higher timeframe.

Key Financials

Market Cap
$1.5B
Avg Volume (60D)
719.6K
60 sessions
Revenue Growth YoY
+6.5%
FY2025 vs FY2024
Gross Margin
+44.8%
Trailing twelve months
Operating Margin
+4.6%
Trailing twelve months
Free Cash Flow Yield
+9.4%
Distance from 200DMA
-18.1%
Next Earnings
2026-10-29
P/E
38.7x
EV / EBITDA
8.4x
EV / Sales
1.0x
Market metrics as of Sep 22, 2026
Financial results for the period ended Jun 30, 2026
Filed balance-sheet data as of Dec 31, 2025

Fundamentals & Valuation

Two of the three valuation perspectives say cheap; own history is the dissenting view.
Omnicell, Inc. has a Cheap valuation stance because current market expectations look undemanding relative to the cash the business actually produces. It trades at a 9.4% free-cash-flow yield and 8.4x EBITDA, which the underlying economics comfortably support.

Company Research

Thesis
Omnicell is a specialist medication-management technology provider to hospitals and health systems, selling and servicing automated dispensing systems, central-pharmacy automation and robotics, IV-compounding workflow, connected software and analytics, and related technical, SaaS, and expert services.
Opportunity
Moderate opportunity
Hospitals and health systems are adopting connected dispensing, central-pharmacy robotics, sterile-compounding workflow, medication inventory, and clinical workflow systems to reduce labor intensity, improve medication safety, and increase operational throughput amid staffing constraints and cost pressure.
Key risk
Dependence on hospital and health system capital spending.

Narrative & Theme

Healthcare Delivery Labor Productivity and Automation
Part of Hospital Pharmacy and Medication-Workflow Automation, with strong fit.
OMCL has direct, revenue-bearing exposure to a specific hospital capital-and-operating budget: medication-use automation.
Narrative HeatNeutral5.4 / 10
This reading is no longer current (last measured 2026-08-14). It is kept until the next scheduled measurement replaces it.
Theme HeatNeutral6.1 / 10
This is the company’s own research reading. The canonical heat measurement for this story has not run.

Business & Markets

Healthcare · Health Information Services
What they do

Omnicell, Inc. provides healthcare technology solutions primarily for hospitals and health systems, focusing on medication management and clinician workflow automation both in the United States and internationally.

How it earns

The company generates revenue mainly through the sale and service of automated dispensing systems and related healthcare technology solutions.

Products & services
Titan XT automated dispensing system
XTExtend console swap
Central Pharmacy Dispensing Service
Central Med Automation Service
IV Compounding Service
Specialty pharmacy services
Customers & end markets
Hospitals
Health systems
Market position

Omnicell is a recognized provider in the healthcare technology space with a focus on medication dispensing automation solutions.

Demand drivers
Low cyclicality

Demand for healthcare technology and medication management solutions tends to be stable and less sensitive to economic cycles.

Related companies

Finding other covered companies in the same part of this story…